Evaluation of oclacitinib maleate and prednisolone combined therapy for the control of atopic dermatitis in dogs: A controlled clinical trial

Documenti analoghi

• Evaluation of filaggrin 2 expression in dogs with atopic dermatitis before and after oclacitinib maleate administration
  di: Wendie Roldan Villalobos, et al.
  Pubblicazione: (2025)
• Comparative study of a commercial formula containing natural antimicrobials versus oral cephalexin or topical chlorhexidine‐miconazole therapies for treating superficial pyoderma in dogs
  di: Vanessa Cunningham Gmyterco, et al.
  Pubblicazione: (2025)
• Comparative efficacy and safety of ilunocitinib and oclacitinib for the control of pruritus and associated skin lesions in dogs with atopic dermatitis
  di: Sophie Forster, et al.
  Pubblicazione: (2025)
• Efficacy and field safety of ilunocitinib for the control of atopic dermatitis in client‐owned dogs: A multicentre, double‐masked, randomised, placebo‐controlled clinical trial
  di: Sophie Forster, et al.
  Pubblicazione: (2025)
• A placebo‐controlled, double‐blind study evaluating the effect of orally administered polyunsaturated fatty acids on the oclacitinib dose for atopic dogs
  di: Laura Schäfer, et al.
  Pubblicazione: (2024)